a formal single-blind multicentre study has been set up to investigate the probable benefit of combined therapy of the cytoprotective agent de-nol ( colloidal bismuth subcitrate , cbs ) and an acid-suppressing drug ( cimetidine ) in the treatment of duodenal ulcer .
C0008783
cimetidine
C0013295
duodenal ulcer